Surveillance for dysplasia in inflammatory bowel disease: it is time to move forward

Hazem Hammad; Tonya Kaltenbach; Roy Soetikno

doi:10.1055/s-0043-100097

Endoscopy, Table of Contents

Endoscopy 2017; 49(02): 110-112
DOI: 10.1055/s-0043-100097

Editorial

Surveillance for dysplasia in inflammatory bowel disease: it is time to move forward

Refering to ten Hove et al. p. 161–168

Hazem Hammad

¹Division of Gastroenterology and Hepatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA

,

Tonya Kaltenbach

²Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA

,

Roy Soetikno

³Graduate School of Business, Stanford, California, USA.

› Author Affiliations

Abstract

Full Text

References

References
1 Jaramillo E, Watanabe M, Befrits R. et al. Small, flat colorectal neoplasias in long-standing ulcerative colitis detected by high-resolution electronic video endoscopy. Gastrointest Endosc 1996; 44: 15-22
2 Rutter MD, Saunders BP, Wilkinson KH. et al. Most dysplasia in ulcerative colitis is visible at colonoscopy. Gastrointest Endosc 2004; 60: 334-339
3 Carballal S, Maisterra S, Lopez-Serrano A. et al. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD. Gut 2000;
4 Laine L, Kaltenbach T, Barkun A. et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc 2015; 81: 489-501 e26
5 Van Assche G, Dignass A, Bokemeyer B. et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis 2013; 7: 1-33
6 Shergill AK, Lightdale JR. American Society for Gastrointestinal Endoscopy Standards of Practice C. et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc 2015; 81: 1101-1121 , e1–e13
7 Rubin DT, Krugliak Cleveland N, Rodriquez DM. Outcomes of colitis-associated dysplasia after referral from the community to a tertiary center. Gastrointest Endosc 2016; 84: 1078-1079
8 Gasia MF, Ghosh S, Panaccione R. et al. Targeted biopsies identify larger proportions of patients with colonic neoplasia undergoing high-definition colonoscopy, dye chromoendoscopy, or electronic virtual chromoendoscopy. Clin Gastroenterol Hepatol 2016; 14: 704-712 , e4
9 Watanabe T, Ajioka Y, Mitsuyama K. et al. Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer. Gastroenterology 2016; 151: 1122-1130
10 Soetikno R, Subramanian V, Kaltenbach T. et al. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology 2013; 144: 1349-1352 , 52 e1–e6
11 Matsumoto T, Iwao Y, Igarashi M. et al. Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis. Inflamm Bowel Dis 2008; 14: 259-264
12 Ueno Y, Tanaka S, Chayama K. Non-polypoid colorectal neoplasms in ulcerative colitis. Gastrointest Endosc Clin N Am 2010; 20: 525-542
13 Soetikno R, Sanduleanu S, Kaltenbach T. An atlas of the nonpolypoid colorectal neoplasms in inflammatory bowel disease. Gastrointest Endosc Clin N Am 2014; 24: 483-520
14 Kaltenbach T, McQuaid K, Sanchez-Yague A. et al. Chromoendoscopy with targeted biopsy to detect nonpolypoid colorectal neoplasms in IBD 2014 ASGE Educational Products and CME Program Audiovisual Award. Available from: https://www.youtube.com/watch?v=OARkbgwlObI
15 Soetikno RM, Kaltenbach T, Rouse RV. et al. Prevalence of nonpolypoid (flat and depressed) colorectal neoplasms in asymptomatic and symptomatic adults. JAMA 2008; 299: 1027-1035
16 ten Hove JR, Mooiweer E, van der Meulen de Jong AE. et al. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy. Endoscopy 2017; 49: 161-168